Not a good buy right now: the broader trend is still bearish (SMA200 > SMA20 > SMA5) and there are no Intellectia buy signals to justify an impatient entry.
Price is sitting right at the first resistance (R1 ~ 89.03) in pre-market, which increases near-term rejection risk versus favorable upside skew.
Fundamentals are mixed (revenue still shrinking), and the most recent sell-side update kept a Neutral stance with a lowered target, reinforcing limited conviction.
If you must act immediately, CABO is better treated as a wait/hold name until it either reclaims trend (MA structure flips) or pulls back closer to support (~80.96 pivot).
Trend/structure: Bearish moving average stack (SMA_200 > SMA_20 > SMA_5) indicates the primary trend is still down despite a short-term bounce.
Momentum: MACD histogram +1.528 and expanding suggests improving momentum, but it is fighting the bearish MA structure (often a counter-trend rally until proven otherwise).
RSI(6)=67.12: near the upper end of neutral; getting closer to overbought, which reduces the attractiveness of a fresh chase-buy.
Key levels: Pivot support ~80.96 (closer to a better risk/reward entry), resistance R1 ~89.03 (current pre-market ~89.02 is basically at resistance), next resistance R2 ~94.02.
Probabilistic trend (pattern analogs): ~70% chance of -0.51% next day, +1.12% next week, -2.21% next month—near-term chop, weaker month outlook.
Positive Catalysts
Profitability metrics improved in the latest reported quarter (net income and EPS up sharply; gross margin slightly higher).
Takeaway: profitability improved sharply, but the ongoing revenue decline keeps the longer-term growth profile unattractive.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Most recent update (2025-11-12): JPMorgan maintains Neutral and خفض price target to $145 from $175 after earnings, citing weak momentum.
Wall Street “pros” view (based on provided data): improved profitability and potential mean-reversion upside if execution stabilizes.
Wall Street “cons” view: demand/momentum remains weak and revenue is still declining, limiting conviction for an immediate buy.
Influential trading (politicians/congress): No recent congress trading data available (no signal from that channel).
Wall Street analysts forecast CABO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CABO is 202.5 USD with a low forecast of 145 USD and a high forecast of 260 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast CABO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CABO is 202.5 USD with a low forecast of 145 USD and a high forecast of 260 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
0 Sell
Hold
Current: 100.820
Low
145
Averages
202.5
High
260
Current: 100.820
Low
145
Averages
202.5
High
260
JPMorgan
Neutral
downgrade
$175 -> $145
AI Analysis
2025-11-12
Reason
JPMorgan
Price Target
$175 -> $145
AI Analysis
2025-11-12
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Cable One to $145 from $175 and keeps a Neutral rating on the shares post the earnings report. The firm says the company's momentum remains weak.
BNP Paribas Exane
Underperform -> Neutral
upgrade
$125
2025-06-17
Reason
BNP Paribas Exane
Price Target
$125
2025-06-17
upgrade
Underperform -> Neutral
Reason
BNP Paribas Exane upgraded Cable One to Neutral from Underperform with a $125 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CABO
